Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Latest News about ABBV

Recent news which mentions ABBV

< Previous 1 2 3 4 5 6 7 8 9
...
73 74 Next >
AbbVie-Roche's Venclexta Shows Progression-Free Survival Of 74% In CLL Patients After Three Years Treatment
Tickers ABBV RHHBF RHHBY RHHVF
Tags RHHBF FDA Market News
From Benzinga
3 Absurdly Cheap Stocks to Buy in a Ridiculously Expensive Market
Tickers ABBV BMY PFE VTRS
Tags BMY ABBV Market News
From Motley Fool
'Halftime Report' Traders Share Their Thoughts On Gilead, IBM And More
Tickers ABBV ERIC GILD IBM
Tags Pete Najarian Benzinga Market News
From Benzinga
2 Top Healthcare Stocks to Buy in a Market Crash
Tickers ABBV VEEV
Tags ABBV Market News VEEV
From Motley Fool
2 High-Yield Dividend Stocks for 2021
Tickers ABBV ABT PFE
Tags ABBV PFE Market News
From Motley Fool
AbbVie, Caraway Therapeutics Team Up To Develop TMEM175 Modulators For Parkinson's Disease
Tickers ABBV
Tags Health Care Market News Benzinga
From Benzinga
AbbVie's Ibrutinib/Venetoclax Combo Potentially Chemo-free, Fixed-Duration Treatment Option in Leukemia
Tickers ABBV
Tags General Biotech Health Care
From Benzinga
The Week Ahead In Biotech: Biogen, Alexion And Vertex FDA Decisions, Multiple Conference Presentations On The Deck
Tickers ABBV ADMP AGIO ALKS
Tags BMY Market News AZN
From Benzinga
Argenx Regains Global Rights from Johnson & Johnson to Blood Cancer Candidate Cusatuzumab
Tickers ABBV ARGX JNJ RHHBF
Tags RHHVF Earnings ARGX
From Benzinga
Lilly's Olumiant Found to Lower Pain In Late-Stage Rheumatoid Arthritis Trial
Tickers ABBV INCY LLY
Tags rheumatoid arthritis Phase 3 Trial News
From Benzinga
Almost Half of Crohn's Disease Patients Achieved Endoscopic Response After One Year of Maintenance Treatment with AbbVie's Risankizumab
Tickers ABBV
Tags News Briefs Crohn's Disease
From Benzinga
AbbVie's Rinvoq Shows Encouraging Long Term Safety, Efficacy In Rheumatoid Arthritis, Psoriatic Arthritis Patients
Tickers ABBV
Tags Biotech Market News Health Care
From Benzinga
Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates
Tickers ABBV ALXN APLS ASND
Tags BIIB LNTH LMNL
From Benzinga
Is Viatris a Good Stock to Buy for 2021?
Tickers ABBV AMGN PFE SPY
Tags AMGN ABBV Market News
From Motley Fool
The Smartest Dividend Stocks to Buy With $400 Right Now
Tickers ABBV ABT BEP BEPC
Tags BEP Market News IIPR
From Motley Fool
Got $5,000? Buy These 2 Stocks Instead of Dogecoin
Tickers ABBV NVAX
Tags ABBV NVAX Market News
From Motley Fool
Balancing Portfolio Risk And Reward: Asset Allocation for New Graduates
Tickers ABBV AFRM AGG AMT
Tags XSW PYPL COLD
From InvestorPlace
2 Stocks to Buy With Dividends Yielding More Than 3%
Tickers ABBV AMCR
Tags Market News AMCR ABBV
From Motley Fool
The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-Term Migraine Drug Data, Decision Day For Eton, 2 IPOs
Tickers ABBV ANPC ASMB ASND
Tags BOLT LEGN VKTX
From Benzinga
5 Stocks Warren Buffett Is Selling That You Should Be Buying
Tickers ABBV BMY BRK-A BRK-B
Tags BRK/B BRK/A ABBV
From Motley Fool
Progenity's Targeted Delivery Of Adalimumab Shows Encouraging Action In Animal Models Induced With Colitis
Tickers ABBV PROG
Tags Penny Stocks General Biotech
From Benzinga
5 Reasons Not to Sell During a Market Crash
Tickers ABBV COST
Tags ABBV Market News COST
From Motley Fool
2 Smart Stocks to Pick During a Market Correction
Tickers ABBV ENDP GM JNJ
Tags ABBV VWAGY TSLA
From Motley Fool
AbbVie-Roche Win European Approval for Venclyxto in Newly Diagnosed Acute Myeloid Leukemia
Tickers ABBV RHHBF RHHBY RHHVF
Tags Biotech European Commission ABBV
From Benzinga
Amazon and Facebook as defensive plays? Yes, along with these other stocks that are cash-flow winners
Tickers AAPL ABBV AMZN CVS
Tags GOOGL AAPL ABBV
From MarketWatch
2 High-Yield Dividend Stocks for 2021
Tickers ABBV ABT BMY SPY
Tags ABT SPY Market News
From Motley Fool
3 Strong Stocks for Your Income Tax Return
Tickers ABBV OMI PKI
Tags ABBV PKI Market News
From Motley Fool
Will the COVID Vaccine Companies Fall off the Patent Cliff?
Tickers ABBV BNTX MRNA NVAX
Tags NVAX BNTX ABBV
From Motley Fool
JNJ's Stelara Fails to Beat AbbVie's Humira In Crohn's Disease Patients
Tickers ABBV JNJ
Tags ABBV Briefs Crohn's Disease
From Benzinga
The Best Dividend Aristocrats to Buy With $500 Right Now
Tickers ABBV ABT KO LOW
Tags ABBV Market News LOW
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
73 74 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.